Cutting Edge: Dendritic Cells Are Essential for in Vivo IL-12 Production and Development of Resistance Against Toxoplasma Gondii Infection in Mice

Journal of Immunology - United States
doi 10.4049/jimmunol.177.1.31
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Cutting Edge: Bradykinin Induces IL-12 Production by Dendritic Cells: A Danger Signal That Drives Th1 Polarization

Journal of Immunology
AllergyImmunology
2003English

Cutting Edge: mTORC1 in Intestinal CD11c+CD11b+ Dendritic Cells Regulates Intestinal Homeostasis by Promoting IL-10 Production

Journal of Immunology
AllergyImmunology
2012English

UNC93B1 Is Essential for TLR11 Activation and IL-12-dependent Host Resistance toToxoplasma Gondii

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Rifapentine Is Active in Vitro and in Vivo Against Toxoplasma Gondii.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

Involvement of Host Defense Mechanisms Against Toxoplasma Gondii Infection in Anhedonic and Despair-Like Behaviors in Mice

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2017English

In Vivo Efficacy of Drugs Against Toxoplasma Gondii Combined With Immunomodulators

Japanese Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2016English

Human Lymphokine-Activated Killer Cells Are Cytotoxic Against Cells Infected With Toxoplasma Gondii

Journal of Experimental Medicine
MedicineAllergyImmunology
1992English

Inflammatory Monocytes but Not Neutrophils Are Necessary to Control Infection With Toxoplasma Gondii in Mice

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2010English

Targeted Delivery of Toxoplasma Gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency Against Toxoplasmosis

Frontiers in Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy